Rescription® Awarded Utility Patent for Point-of-Sale 340B Adjudication Technology
Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S. utility patent for its proprietary claims adjudication technology that enables 340B pricing to be applied in real-time at the point-of-sale.
